Home Newsletters Cell Therapy News Impact of Mother Donor, Peripheral Blood Stem Cells and Measurable Residual Disease...

Impact of Mother Donor, Peripheral Blood Stem Cells and Measurable Residual Disease on Outcomes after Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Children with Acute Leukemia

0
Investigators analyzed 144 acute leukemia haploidentical hematopoietic-cell transplantation using post-transplant cyclophosphamide pediatric recipients; median age was ten years.
[Bone Marrow Transplantation]

Sorry, but the selected Zotpress account can't be found.

Abstract
Exit mobile version